Evidence map›Paper›PMID 32041604›Full record

ArticleBMC medical genomics2020

Master and servant: LINC00152 - a STAT3-induced long noncoding RNA regulates STAT3 in a positive feedback in human multiple myeloma.

Stefanie Binder, Ivonne Zipfel, Maik Friedrich, Diana Riedel, Stefanie Ende, Christoph Kämpf, Karolin Wiedemann, Tilo Buschmann, Sven-Holger Puppel, Kristin Reiche and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. The impact of STAiR18 on multiple myeloma survival rates.Journal of translational medicine · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 4 countries.

Stefanie BinderInstitute of Clinical Immunology, Faculty of Medicine, University of Leipzig, Leipzig, Germany. stefanie.binder@medizin.uni-leipzig.de.
Ivonne ZipfelInstitute of Clinical Immunology, Faculty of Medicine, University of Leipzig, Leipzig, Germany.
Maik FriedrichInstitute of Clinical Immunology, Faculty of Medicine, University of Leipzig, Leipzig, Germany.
Diana RiedelInstitute of Clinical Immunology, Faculty of Medicine, University of Leipzig, Leipzig, Germany.
Stefanie EndeInstitute of Clinical Immunology, Faculty of Medicine, University of Leipzig, Leipzig, Germany.
Christoph KämpfFraunhofer Institute for Cell Therapy and Immunology, Department of Diagnostics, Leipzig, Germany.
Karolin WiedemannFraunhofer Institute for Cell Therapy and Immunology, Department of Diagnostics, Leipzig, Germany.
Tilo BuschmannFraunhofer Institute for Cell Therapy and Immunology, Department of Diagnostics, Leipzig, Germany.
Sven-Holger PuppelFraunhofer Institute for Cell Therapy and Immunology, Department of Diagnostics, Leipzig, Germany.
Kristin ReicheFraunhofer Institute for Cell Therapy and Immunology, Department of Diagnostics, Leipzig, Germany.
Peter F StadlerBioinformatics Group, Department of Computer Science, and Interdisciplinary Center for Bioinformatics, University of Leipzig, Leipzig, Germany.
Friedemann HornInstitute of Clinical Immunology, Faculty of Medicine, University of Leipzig, Leipzig, Germany.
Fraunhofer Institute for Cell Therapy and Immunology · DELeipzig University · DEUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe survival of INA-6 human multiple myeloma cells is strictly dependent upon the Interleukin-6-activated transcription factor STAT3. Although transcriptional analyses have revealed many genes regulated by STAT3, to date no protein-coding STAT3 target gene is known to mediate survival in INA-6 cells. Therefore, the aim here was to identify and analyze non-protein-coding STAT3 target genes. In addition to the oncogenic microRNA-21, we previously described five long noncoding RNAs (lncRNAs) induced by STAT3, named STAiRs. Here, we focus on STAT3-induced RNA 18 (STAiR18), an mRNA-like, long ncRNA that is duplicated in the human lineage. One STAiR18 locus is annotated as the already well described LINC00152/CYTOR, however, the other harbors the MIR4435-2HG gene and is, up to now, barely described.

methodsCAPTURE-RNA-sequencing was used to analyze STAiR18 transcript architecture. To identify the STAiR18 and STAT3 phenotype, siRNA-based knockdowns were performed and microarrays were applied to identify their target genes. RNA-binding partners of STAiR18 were determined by Chromatin-Isolation-by-RNA-Purification (ChIRP) and subsequent sequencing. STAT3 expression in dependence of STAiR18 was investigated by immunoblots, chromatin- and RNA-immunoprecipitations.

resultsAs identified by CAPTURE-RNA sequencing, a complex splice pattern originates from both STAiR18 loci, generating different transcripts. Knockdown of the most abundant STAiR18 isoforms dramatically decreased INA-6 cell vitality, suggesting a functional role in myeloma cells. Additionally, STAiR18 and STAT3 knockdowns yielded overlapping changes of transcription patterns in INA-6 cells, suggesting a close functional interplay between the two factors. Moreover, Chromatin isolation by RNA purification (ChIRP), followed by genome-wide RNA sequencing showed that STAiR18 associates specifically with the STAT3 primary transcript. Furthermore, the knockdown of STAiR18 reduced STAT3 levels on both the RNA and protein levels, suggesting a positive feedback between both molecules. Furthermore, STAiR18 knockdown changes the histone methylation status of the STAT3 locus, which explains the positive feedback and indicates that STAiR18 is an epigenetic modulator.

conclusionHence, STAiR18 is an important regulator of myeloma cell survival and is strongly associated with the oncogenic function of STAT3. The close functional interplay between STAT3 and STAiR18 suggests a novel principle of regulatory interactions between long ncRNAs and signaling pathways.

Indexed as

Feedback, PhysiologicalMultiple MyelomaNeoplasm ProteinsRNA, Long NoncodingRNA, NeoplasmSTAT3 Transcription FactorCell Line, TumorHumansSignal Transductionlong non-coding RNA Linc00152, humanNeoplasm ProteinsRNA, Long NoncodingRNA, NeoplasmSTAT3 protein, humanSTAT3 Transcription FactorCancerCYTOREpigeneticsIL-6 signalingLINC00152ncRNAsSTAT3

Identifiers

PMID32041604
PMCPMC7011539
OpenAlexW3010470448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.